Cambridge Nutritional Sciences (FRA:RVKA) Days Payable: 160.34 (As of Sep. 2025)— 95% Above Median
What is Cambridge Nutritional Sciences Days Payable?
Cambridge Nutritional SciencesFRA:RVKA Days Payable is 160.34 as of Sep. 2025, which is 95% above its 10-year median of 82.31. The stock has 3 warning signs investors should review. Among 795 Medical Devices & Instruments companies, Cambridge Nutritional Sciences ranks better than 78.11% on this metric.
The historical rank and industry rank for Cambridge Nutritional Sciences's Days Payable or its related term are showing as below:
FRA:RVKA'
s Days Payable Range Over the Past 10 Years
Min: 59.34 Med: 82.31 Max: 152.34
Current: 151.44
During the past 13 years, Cambridge Nutritional Sciences's highest Days Payable was 152.34. The lowest was 59.34. And the median was 82.31.
FRA:RVKA's Days Payable is ranked better than 78.11% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 68.07
vs FRA:RVKA: 151.44
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:RVKA vs ISRG, BDX, MDLN: Days Payable Comparison
For the Medical Instruments & Supplies subindustry, Cambridge Nutritional Sciences's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cambridge Nutritional Sciences Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Cambridge Nutritional Sciences's Days Payable distribution charts can be found below:
* The bar in red indicates where Cambridge Nutritional Sciences's Days Payable falls into.
Cambridge Nutritional Sciences Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cambridge Nutritional Sciences (FRA:RVKA) has a Days Payable of 160.34 as of Sep. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Cambridge Nutritional Sciences and its competitors. This is 95% above median its historical median of 82.31. Over the past decade, Cambridge Nutritional Sciences' Days Payable has ranged from 59.34 to 152.34. According to the industry distribution chart, Cambridge Nutritional Sciences ranks #174 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 21.9%.
Is Cambridge Nutritional Sciences' Days Payable too high?
Cambridge Nutritional Sciences' current Days Payable of 160.34 is 95% above median its 10-year median of 82.31. Over the past 10 years, this metric has ranged from a low of 59.34 to a high of 152.34. The Medical Devices & Instruments industry median Days Payable is 68.07. Cambridge Nutritional Sciences' value of 160.34 is 135.6% above this industry median. Based on the distribution chart, Cambridge Nutritional Sciences ranks #174 out of 795 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers.
How does Cambridge Nutritional Sciences' Days Payable compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Cambridge Nutritional Sciences ranks #174 out of 795 companies for Days Payable. This places Cambridge Nutritional Sciences in the top 22% of its industry — outperforming the majority of peers. The industry median Days Payable is 68.07. Cambridge Nutritional Sciences' value of 160.34 is 135.6% above this benchmark. Historically, Cambridge Nutritional Sciences' own Days Payable has ranged from 59.34 to 152.34 over the past decade. While the company's 10-year median is 82.31 vs. the industry median of 68.07, Cambridge Nutritional Sciences has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 68.07, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cambridge Nutritional Sciences's current Days Payable of 160.34 is 135.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Cambridge Nutritional Sciences and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 68.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cambridge Nutritional Sciences's current Days Payable is 160.34, which is 95% above median its own 10-year median of 82.31. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cambridge Nutritional Sciences stock overvalued right now?
Cambridge Nutritional Sciences (FRA:RVKA) has a current Days Payable of 160.34. The stock's GF Value™ is €0.02, compared to a current price of €0.01 — trading 32.5% below its estimated fair value. The current Days Payable is 160.34, which is 95% above median its 10-year median of 82.31 and 135.6% above the Medical Devices & Instruments industry median of 68.07. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Cambridge Nutritional Sciences (FRA:RVKA), the current Days Payable is 160.34 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Cambridge Nutritional Sciences Business Description
Cambridge Nutritional Sciences PLC is a medical diagnostics company specializing in the development, manufacture, and distribution of food sensitivity test kits. Its product portfolio includes tests designed to detect immune reactions to various foods, helping healthcare professionals and patients identify dietary and lifestyle changes to improve long-term health and wellbeing. The company operates in the United Kingdom and serves the customer base across various countries through laboratories and healthcare providers. It generates revenue by selling diagnostic kits and providing clinical analysis services centered on food sensitivity and gut health. The group has two reportable segments: Health and Nutrition; and Corporate. The Health and Nutrition segment generates majority revenue.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:RVKA has been successfully added to your 